(April 15, 2024, 2:32 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) refused to transfer a case pending in a Hawaii federal court in which the state alleges “a scheme to inflate the list price of all ‘brand-name prescription drugs’ — a substantially larger universe of drugs, manufacturers, and business practices than those at issue in the MDL” that centralized federal insulin pricing lawsuits....